
Sign up to save your podcasts
Or
Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinosinusitis.
Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00097-7/fulltext
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
5
11 ratings
Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinosinusitis.
Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00097-7/fulltext
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
131 Listeners
2,052 Listeners
3 Listeners
325 Listeners
34 Listeners
496 Listeners
23 Listeners
20 Listeners
0 Listeners
0 Listeners
2 Listeners
1 Listeners
0 Listeners
1 Listeners
0 Listeners
15,335 Listeners
0 Listeners
1 Listeners
0 Listeners
1 Listeners
0 Listeners
0 Listeners
0 Listeners
24 Listeners
0 Listeners
0 Listeners
0 Listeners
819 Listeners
2,300 Listeners
0 Listeners